Daesung Microbiological Labs. Co., Ltd.

Research Daesung Microbiological Labs. Co., Ltd. (036480.KQ) on Bullrun: market cap KRW 22.00B, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 22.00B; dividend yield is 1.3%.

Peer valuation comparison

Latest dividend yield is 1.3% versus a Healthcare sector median of 2.4% (45.8% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 22.00Bn/a1.3%75

Dividend history

Latest trailing dividend snapshot: annual dividend/share 75 KRW, yield 1.3%.

About Daesung Microbiological Labs. Co., Ltd.

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Daesung Microbiological Labs. Co., Ltd.'s market cap?

Daesung Microbiological Labs. Co., Ltd.'s market capitalization is KRW 22.00B.

Does Daesung Microbiological Labs. Co., Ltd. pay a dividend?

Daesung Microbiological Labs. Co., Ltd. has a dividend yield of 1.3%.

What does Daesung Microbiological Labs. Co., Ltd. do?

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea.